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the receiver operating characteristic curve analysis, 60% reduction of 
CEA level should be an appropriate cut-off value in predicting good 
response to the chemotherapy. In this condition, the sensitivity and 
spescifciity of CEA for RECIST were 82.8% and 69.2%, respectively.
Conclusions: Determination of changes in serum CEA level appeared 
to be useful as an surrogate index for evaluation of tumor response to 
chemotherapy that would result in comparable judgment with RECIST 
in patients with NSCLC who had elevated CEA level before treatment.
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Background: Although there have been many controversies in lung 
cancer screening, low-dose CT (LDCT) is currently used in clinical 
research studies or even in practice in many countries. There are few 
reports about lung cancer screening with LDCT from Asia except 
Japan.
Materials and Methods: Between May 2001 and February 2006, a 
total of 11,974 asymptomatic adults (≥ 40 years) who underwent LDCT 
for lung cancer screening were retrospectively analyzed. We assessed 
overall detection rates, demographic ﬁndings, staging, histology, and 
CT ﬁndings of lung cancers found on LDCT. 
Results: There were 6,612 men and 5,362 women with age range from 
40 to 92 years (mean, 53.7±8.2 years). Lung cancers were detected in 
25 individuals (0.21%) either initial (n=20) or annual follow-up LDCT 
(n=5). They were 12 men and 13 women with age range from 45 to 
73 years (mean, 58±8 years). Fifteen patients were non-smokers and 
10 were smokers. They were all non-small cell cancer (16 stage IA, 5 
stage IB, 1 stage II, and 3 stage IIIA) with the histology of bronchio-
loalveolar carcinoma (BAC, n=8), adenocarcinoma (n=14), squamous 
cell (n=2) and large cell carcinoma (n=1). Twenty-six lesions in 24 
patients appeared as a nodule with ground-glass opacity (GGO, n=5), 
mixed GGO (n=9) or solid (n=12) with mean size of 17.6±6.7 mm 
(range, 5-36 mm) while only one as endobronchial mass. The histologic 
type of GGO or mixed GGO nodule was BAC or adenocarcinoma 
with BAC features. Four BAC appeared as solid nodules. Details of 
four symptom-diagnosed cancers were given in Table 1. They were all 
smokers.
Patient Sex
Age 
(years)
Histology Stage
Interval 
(months)
Findings in 
initial LDCT
1 M 53 Squamous IB 8 Focal bronchial thickening
2 M 54 NSCLC IV 30 Peripheral solid nodule (7mm)
3 M 56 Adeno, PD IIIB 37 Subtle hilar bulging
4 M 46 Adeno, PD IV 29 Normal even on retrospect
Conclusion: The overall detection rate was 0.21% in LDCT screening 
of asymptomatic adults older than 40 years. Most of screen-detected 
lung cancers were stage I (84%) with histology of adenocarcinoma 
including BAC. More than 90% of screen detected lung cancers were 
appeared as a peripheral nodule with either GGO, mixed or solid. 
Symptom-detected lung cancers were more aggressive and could be 
unrecognized since they are located in central on initial LDCT scans. 
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Background: Bronchioloalveolar cell carcinoma (BAC) component 
is a prognostic indicator and well correlated with GGO area on HRCT. 
However, it does not always appeared as GGO area. The purpose of our 
study was to determine the histologic ﬁndings of non-GGO area when 
there is discrepancy between the area of GGO on CT and BAC area on 
histopathology.
Materials and Methods: The subjects were 66 patients with BAC and 
adenocarcinoma with BAC feature smaller than 3 cm in largest diam-
eter in who underwent lung resection between March 2001 and June 
2004. They were 29 men and 37 women with mean age of 62.1 years 
(range, 42 - 82 years). The extent of the GGO of nodule was classiﬁed 
into grade 1 (≤50%), grade 2 (50-90%), and grade 3 (≥90%) accord-
ing to tumor disappearance rate (TDR %) in section with maximal 
diameter of the nodule on HRCT. TDR % was deﬁned as [1 - (maximal 
diameter×perpendicular diameter on mediastinal windows/maximal 
diameter×perpendicular diameter on lung windows)] ×100. One pa-
thologist retrospectively reviewed the extent of area of BAC classiﬁed 
into grade 1 (≤50%), grade 2 (50-90%), and grade 3 (≥90%) without 
knowledge of CT results on representative section of pathologic slide. 
When there is discrepancy the grade between CT and pathologic slide, 
slides were reviewed further evaluation of other histologic ﬁndings in 
BAC area.
Results: The relationship between TDR and Histologic BAC% was 
given in Table 1.
Table 1: BAC % correlated with TDR (p<0.0001, Kruskal-Wallis test) 
BAC%/TDR% 1 2 3 Total
1 27 2  31
2 14 4  18
3 6 (2)* 4 (2)* 9 (4)* 19
Total 47 4 9 66
* numbers in parenthesis are pure BAC.HRCT underestimated BAC component in 24 cases and overes-
timated in two cases. The histologic components producing underestimation of BAC component were 
lymphocytic inﬁltration with or without intraalveolar macrophage (n=8), Aleolar collapse (n=6), mucin 
in alveolar space (n=4) and intraalveolar macrophage (n=3), etc. Overestimation of BAC component was 
related to intratumoral lucencies in two cases. 
Conclusion: BAC % was correlated with ground-glass opacity area on 
HRCT. BAC component did not always appear as ground-glass opacity 
on HRCT. Underestimation of BAC component on HRCT was related 
to lymphocytic inﬁltration in interstitium, intraalveolar macrophage and 
mucin in alveolar space and alveolar collapse.
